Cost-utility analysis of a medication review with follow-up service for older adults with polypharmacy in community pharmacies in Spain: the conSIGUE program.

dc.centroFacultad de Ciencias Económicas y Empresarialeses_ES
dc.contributor.authorJódar-Sánchez, Francisco
dc.contributor.authorMalet-Larrea, Amaia
dc.contributor.authorMartín, José J.
dc.contributor.authorGarcía-Mochón, Leticia
dc.contributor.authorLópez del Amo, M. Puerto
dc.contributor.authorMartínez-Martínez, Fernando
dc.contributor.authorGastelurrutia-Garralda, Miguel A.
dc.contributor.authorGarcía-Cárdenas, Victoria
dc.contributor.authorSabater-Hernández, Daniel
dc.contributor.authorSáez-Benito, Loreto
dc.contributor.authorBenrimoj, Shalom I
dc.date.accessioned2024-09-28T09:57:01Z
dc.date.available2024-09-28T09:57:01Z
dc.date.issued2015
dc.departamentoEconomía Aplicada (Estadística y Econometría)
dc.descriptionhttps://v2.sherpa.ac.uk/id/publication/18274es_ES
dc.description.abstractObjective: The objective of this study was to estimate the incremental cost-effectiveness ratio (ICER) of a medication review with follow-up (MRF) service for older adults with polypharmacy in Spanish community pharmacies against the alternative of having their medication dispensed normally. Methods: The study was designed as a cluster randomized controlled trial, and was carried out over a time horizon of 6 months. The target population was older adults with polypharmacy, defined as individuals taking five or more medicines per day. The study was conducted in 178 community pharmacies in Spain. Cost-utility analysis adopted a health service perspective. Costs were in euros at 2014 prices and the effectiveness of the intervention was estimated as quality-adjusted life-years (QALYs). In order to analyze the uncertainty of ICER results, we performed a non-parametric bootstrapping with 5000 replications. Results: A total of 1403 older adults, aged between 65 and 94 years, were enrolled in the study: 688 in the intervention group (IG) and 715 in the control group (CG). Older adults in the IG saw their quality of life improved by 0.0528 ± 0.20 (p < 0.001). In contrast, the CG experienced a slight reduction in their quality of life: 0.0022 ± 0.24 (p = 0.815). The mean total cost was €977.57±1455.88 for the IG and E1173.44 ± 3671.65 for the CG. In order to estimate the ICER, we used the costs adjusted for baseline medications and QALYs adjusted for baseline utility score, resulting in a mean incremental total cost of -€250.51 ± 148.61 (95 % CI -541.79 to 40.76) and a mean incremental QALY of 0.0156 ± 0.004 (95 % CI 0.008-0.023). Conclusion: The MRF service is an effective intervention for optimizing prescribed medication and improving quality of life in older adults with polypharmacy in community pharmacies. The results from the cost-utility analysis suggest that the MRF service is cost effective.es_ES
dc.description.sponsorshipSpanish General Council of Official Colleges of Pharmacists and CINFA Laboratory.es_ES
dc.identifier.citationJódar-Sánchez, F., Malet-Larrea, A., Martín, J. J., García-Mochón, L., López Del Amo, M. P., Martínez-Martínez, F., Gastelurrutia-Garralda, M. A., García-Cárdenas, V., Sabater-Hernández, D., Sáez-Benito, L., & Benrimoj, S. I. (2015). Cost-utility analysis of a medication review with follow-up service for older adults with polypharmacy in community pharmacies in Spain: the conSIGUE program. PharmacoEconomics, 33(6), 599–610. https://doi.org/10.1007/s40273-015-0270-2es_ES
dc.identifier.doi10.1007/s40273-015-0270-2
dc.identifier.urihttps://hdl.handle.net/10630/33815
dc.language.isoenges_ES
dc.publisherSpringer Naturees_ES
dc.rights.accessRightsopen accesses_ES
dc.subjectFarmacias - Aspectos económicoses_ES
dc.subject.otherEvaluación económicaes_ES
dc.subject.otherSeguimiento farmacoterapéuticoes_ES
dc.subject.otherAños de vida ajustados por calidades_ES
dc.subject.otherFarmacia comunitariaes_ES
dc.subject.otherCostees_ES
dc.titleCost-utility analysis of a medication review with follow-up service for older adults with polypharmacy in community pharmacies in Spain: the conSIGUE program.es_ES
dc.typejournal articlees_ES
dc.type.hasVersionAMes_ES
dspace.entity.typePublication
relation.isAuthorOfPublication6480c293-62ce-45b2-a293-842395e17f3c
relation.isAuthorOfPublication.latestForDiscovery6480c293-62ce-45b2-a293-842395e17f3c

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
7. Pharmacoeconomics, 2015.pdf
Size:
1.49 MB
Format:
Adobe Portable Document Format
Description:

Collections